Literature DB >> 31123147

Implantable multireservoir device with stimulus-responsive membrane for on-demand and pulsatile delivery of growth hormone.

Seung Ho Lee1,2, Huiyan Piao3, Yong Chan Cho4, Se-Na Kim4, Goeun Choi5, Cho Rim Kim4, Han Bi Ji4, Chun Gwon Park6, Cheol Lee7, Chong In Shin8, Won-Gun Koh9, Young Bin Choy10,4,8, Jin-Ho Choy11,5,12.   

Abstract

Implantable devices for on-demand and pulsatile drug delivery have attracted considerable attention; however, many devices in clinical use are embedded with the electronic units and battery inside, hence making them large and heavy for implantation. Therefore, we propose an implantable device with multiple drug reservoirs capped with a stimulus-responsive membrane (SRM) for on-demand and pulsatile drug delivery. The SRM is made of thermosensitive POSS(MEO2MA-co-OEGMA) and photothermal nanoparticles of reduced graphene oxide (rGO), and each of the drug reservoirs is filled with the same amount of human growth hormone (hGH). Therefore, with noninvasive near-infrared (NIR) irradiation from the outside skin, the rGO nanoparticles generate heat to rupture the SRM in the implanted device, which can open a single selected drug reservoir to release hGH. Therefore, the device herein is shown to release hGH reproducibly only at the times of NIR irradiation without drug leakage during no irradiation. When implanted in rats with growth hormone deficiency and irradiated with an NIR light from the outside skin, the device exhibits profiles of hGH and IGF1 plasma concentrations, as well as body weight change, similar to those in animals treated with conventional s.c. hGH injections.

Entities:  

Keywords:  drug delivery; implantable device; near-infrared light; stimulus-responsive membrane

Year:  2019        PMID: 31123147      PMCID: PMC6575234          DOI: 10.1073/pnas.1906931116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Neuroendocrine control of growth hormone secretion.

Authors:  E E Müller; V Locatelli; D Cocchi
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

Review 2.  Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery?

Authors:  Bi-Botti C Youan
Journal:  J Control Release       Date:  2004-08-27       Impact factor: 9.776

3.  Electric field effect in atomically thin carbon films.

Authors:  K S Novoselov; A K Geim; S V Morozov; D Jiang; Y Zhang; S V Dubonos; I V Grigorieva; A A Firsov
Journal:  Science       Date:  2004-10-22       Impact factor: 47.728

4.  Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles.

Authors:  Sun Jin Kim; Sei Kwang Hahn; Myung Jin Kim; Duk Hee Kim; Young Phil Lee
Journal:  J Control Release       Date:  2005-04-07       Impact factor: 9.776

5.  Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses.

Authors:  F Roelfsema; N R Biermasz; R G Veldman; J D Veldhuis; M Frölich; W H Stokvis-Brantsma; J M Wit
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

6.  In vivo delivery of BCNU from a MEMS device to a tumor model.

Authors:  Yawen Li; Hong Linh Ho Duc; Betty Tyler; Tiffany Williams; Malinda Tupper; Robert Langer; Henry Brem; Michael J Cima
Journal:  J Control Release       Date:  2005-08-18       Impact factor: 9.776

7.  Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).

Authors:  C P Jerome; D B Burr; T Van Bibber; J M Hock; R Brommage
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

8.  Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.

Authors:  D W Dempster; F Cosman; E S Kurland; H Zhou; J Nieves; L Woelfert; E Shane; K Plavetić; R Müller; J Bilezikian; R Lindsay
Journal:  J Bone Miner Res       Date:  2001-10       Impact factor: 6.741

9.  Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.

Authors:  S M de Muinck Keizer-Schrama; B Rikken; H J Wynne; A C Hokken-Koelega; J M Wit; A Bot; S L Drop
Journal:  J Clin Endocrinol Metab       Date:  1992-04       Impact factor: 5.958

10.  Multi-pulse drug delivery from a resorbable polymeric microchip device.

Authors:  Amy C Richards Grayson; Insung S Choi; Betty M Tyler; Paul P Wang; Henry Brem; Michael J Cima; Robert Langer
Journal:  Nat Mater       Date:  2003-11       Impact factor: 43.841

View more
  3 in total

1.  Construction and Biological Evaluation of Multiple Modification Hollow Mesoporous Silicone Doxorubicin Nanodrug Delivery System.

Authors:  Mengru Hu; Wenjing Zhang; Weidong Chen; Yunna Chen; Qianqian Huang; Qianqian Bao; Tongyuan Lin; Lei Wang; Shantang Zhang
Journal:  AAPS PharmSciTech       Date:  2022-06-27       Impact factor: 3.246

Review 2.  Microelectromechanical Systems (MEMS) for Biomedical Applications.

Authors:  Cristina Chircov; Alexandru Mihai Grumezescu
Journal:  Micromachines (Basel)       Date:  2022-01-22       Impact factor: 2.891

3.  Electrostatically gated nanofluidic membrane for ultra-low power controlled drug delivery.

Authors:  Nicola Di Trani; Antonia Silvestri; Antons Sizovs; Yu Wang; Donald R Erm; Danilo Demarchi; Xuewu Liu; Alessandro Grattoni
Journal:  Lab Chip       Date:  2020-05-05       Impact factor: 6.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.